Literature DB >> 9203965

IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression.

S Till1, S Durham, R Dickason, D Huston, J Bungre, S Walker, D Robinson, A B Kay, C Corrigan.   

Abstract

Interleukin-13 (IL-13) shares many, but not all, of the properties of the prototypic T-helper type 2 (Th2) cytokine IL-4, but its role in allergen-driven T-cell responses remains poorly defined. We hypothesized that allergen stimulation of peripheral blood T cells from patients with atopic disease compared with non-atopic controls results in elevated IL-13 synthesis in the context of a 'Th2-type' pattern. Freshly isolated peripheral blood mononuclear cells (PBMC) obtained from sensitized atopic patients with allergic disease, and non-atopic control subjects, were cultured with the allergens Phleum pratense (Timothy grass pollen) or Dermatophagoides pteronyssinus (house dust mite) and the non-allergenic recall antigen Mycobacterium tuberculosis purified protein derivative (PPD). Supernatant concentrations of IL-13, along with IL-5 and interferon-gamma (IFN-gamma) (Th2- and Th1-type cytokines, respectively) were determined by enzyme-linked immunosorbent assay (ELISA). Allergen-induced IL-13 and IL-5 production by T cells from patients with allergic disease was markedly elevated (P = 0.0075 and P = 0.0004, respectively) compared with non-atopic controls, whereas IFN-gamma production was not significantly different. In contrast to allergen, the prototypic Th1-type antigen M. tuberculosis PPD induced an excess of IFN-gamma over IL-13 and IL-5 production, and absolute concentrations of cytokines were not affected by the presence or absence of atopic disease. Addition of exogenous recombinant IFN-gamma or IL-12, cytokines known to inhibit Th2-type responses, significantly inhibited allergen-driven production of both IL-13 and IL-5, but not T-cell proliferation, whereas exogenous IL-4 did not significantly affect production of IL-13 or IL-5. We conclude that allergen-specific T cells from atopic subjects secrete elevated quantities of IL-13 compared with non-atopic controls, in the context of a Th2-type pattern of cytokine production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203965      PMCID: PMC1364034          DOI: 10.1046/j.1365-2567.1997.00218.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

2.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

Authors:  A Minty; P Chalon; J M Derocq; X Dumont; J C Guillemot; M Kaghad; C Labit; P Leplatois; P Liauzun; B Miloux
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

3.  Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.

Authors:  A Tsicopoulos; Q Hamid; V Varney; S Ying; R Moqbel; S R Durham; A B Kay
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

4.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

5.  Expression of interleukin 5 by the CD4+CD45R0+ subset of human T cells.

Authors:  W A Sewell; J E Valentine; M A Cooley
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

6.  Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12.

Authors:  T Jung; J Wijdenes; C Neumann; J E de Vries; H Yssel
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

7.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.

Authors:  G F Del Prete; M De Carli; C Mastromauro; R Biagiotti; D Macchia; P Falagiani; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.

Authors:  R de Waal Malefyt; C G Figdor; R Huijbens; S Mohan-Peterson; B Bennett; J Culpepper; W Dang; G Zurawski; J E de Vries
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

9.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

Authors:  R Manetti; P Parronchi; M G Giudizi; M P Piccinni; E Maggi; G Trinchieri; S Romagnani
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.

Authors:  S M Zurawski; F Vega; B Huyghe; G Zurawski
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  24 in total

1.  Elevated allergen-induced IL-13 secretion predicts IgE elevation in children ages 2-5 years.

Authors:  N P Ly; Y Li; D L Sredl; D L Perkins; P W Finn; S T Weiss; D R Gold
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

Review 3.  Cytokine profiles in allergic rhinitis.

Authors:  Guy Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

4.  PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.

Authors:  Daisuke Kozutsumi; Masako Tsunematsu; Taketo Yamaji; Rika Murakami; Minehiko Yokoyama; Kohsuke Kino
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

5.  Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.

Authors:  N Yoshida; Y Shimizu; K Kitaichi; K Hiramatsu; M Takeuchi; Y Ito; H Kume; K Yamaki; R Suzuki; E Shibata; T Hasegawa; K Takagi
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

6.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology.

Authors:  Ulla-Angela Temann; Prabir Ray; Richard A Flavell
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

7.  Interleukin 13 and the evolution of asthma therapy.

Authors:  Gabriele Grünig; David B Corry; Joan Reibman; Marsha Wills-Karp
Journal:  Am J Clin Exp Immunol       Date:  2012-06-30

Review 8.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

Review 9.  Is there a role for treatment of asthma with omalizumab?

Authors:  H Milgrom
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

10.  Requirement for IL-13 independently of IL-4 in experimental asthma.

Authors:  G Grünig; M Warnock; A E Wakil; R Venkayya; F Brombacher; D M Rennick; D Sheppard; M Mohrs; D D Donaldson; R M Locksley; D B Corry
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.